Johnson & Johnson Booster Adds Protection from COVID-19
Johnson & Johnson announced Wednesday that a clinical trial showed a second injection of a COVID-19 vaccine produced a nine times higher antibody response than the US pharmaceutical company’s first dose. In a news release, the company said it had conducted two Phase 1/2a studies on individuals who were previously vaccinated with a single injection. … Read more